» Articles » PMID: 24819581

Osteocytic Cell Necrosis is Caused by a Combination of Glucocorticoid-induced Dickkopf-1 and Hypoxia

Overview
Journal Med Mol Morphol
Publisher Springer
Date 2014 May 14
PMID 24819581
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Osteonecrosis is a major glucocorticoid-induced complication in the orthopedics field. Despite the extensive researches, mechanisms underlining the glucocorticoid-induced osteonecrosis are largely unknown. Here, we first provide the evidence that a combined treatment of cultured osteocytic cells with glucocorticoid and hypoxia caused necrotic cell death, which is assumed to occur in the acute bone injuries induced by glucocorticoids. We cultured MLO-Y4 murine osteocytic cells under hypoxia in the presence or absence of Dexamethasone (Dex) and examined the rates of apoptotic and necrotic cell death. Dex or hypoxia alone increased apoptotic cells, but not necrotic cells. The combination of Dex and hypoxia dramatically increased osteocytic cell death, notably necrotic cell death. The expression of Dickkopf-1 (Dkk-1), an inhibitor of Wnt/β-catenin signal, was scarcely expressed in the control and hypoxic cells, but a dramatic increase of the Dkk-1 expression was detected in Dex-treated cells. siRNA-mediated knockdown of Dkk-1 in Dex and hypoxia-treated osteocytic cells showed the significant decreases in both apoptotic and necrotic cells. The results indicated that the combination of Dkk-1 overexpression by Dex and hypoxia causes the necrotic osteocytic cell death. The results also indicated that blocking of Dkk-1 can protect bone cells from glucocorticoid and hypoxia-induced cell injury.

Citing Articles

Mesenchymal Stem Cells Preconditioned with Hypoxia and Dexamethasone Promote Osteoblast Differentiation Under Stress Conditions.

Shimasaki M, Ichiseki T, Ueda S, Hirata H, Kawahara N, Ueda Y Int J Med Sci. 2024; 21(8):1511-1517.

PMID: 38903930 PMC: 11186427. DOI: 10.7150/ijms.91222.


LncAABR07053481 inhibits bone marrow mesenchymal stem cell apoptosis and promotes repair following steroid-induced avascular necrosis.

Wang T, Xie Z, Wang L, Luo H, Zhang J, Dong W Commun Biol. 2023; 6(1):365.

PMID: 37012358 PMC: 10070412. DOI: 10.1038/s42003-023-04661-0.


Resistance of bone marrow mesenchymal stem cells in a stressed environment - Comparison with osteocyte cells.

Shimasaki M, Ueda S, Ichiseki T, Hirata H, Kawahara N, Ueda Y Int J Med Sci. 2021; 18(6):1375-1381.

PMID: 33628093 PMC: 7893571. DOI: 10.7150/ijms.52104.


Taurine Inhibits Glucocorticoid-Induced Bone Mitochondrial Injury, Preventing Osteonecrosis in Rabbits and Cultured Osteocytes.

Hirata H, Ueda S, Ichiseki T, Shimasaki M, Ueda Y, Kaneuji A Int J Mol Sci. 2020; 21(18).

PMID: 32962196 PMC: 7555938. DOI: 10.3390/ijms21186892.


Mitochondrial Transcription Factor A added to Osteocytes in a Stressed Environment has a Cytoprotective Effect.

Ueda S, Shimasaki M, Ichiseki T, Hirata H, Kawahara N, Ueda Y Int J Med Sci. 2020; 17(9):1293-1299.

PMID: 32547324 PMC: 7294917. DOI: 10.7150/ijms.45335.


References
1.
Rossini M, Gatti D, Adami S . Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int. 2013; 93(2):121-32. DOI: 10.1007/s00223-013-9749-z. View

2.
Mikami T, Ichiseki T, Kaneuji A, Ueda Y, Sugimori T, Fukui K . Prevention of steroid-induced osteonecrosis by intravenous administration of vitamin E in a rabbit model. J Orthop Sci. 2010; 15(5):674-7. DOI: 10.1007/s00776-010-1516-7. View

3.
Saito S, Inoue A, Ono K . Intramedullary haemorrhage as a possible cause of avascular necrosis of the femoral head. The histology of 16 femoral heads at the silent stage. J Bone Joint Surg Br. 1987; 69(3):346-51. DOI: 10.1302/0301-620X.69B3.3584182. View

4.
Wang T, AVLONITIS E, RELKIN R . Systemic necrotizing vasculitis causing bone necrosis. Am J Med. 1988; 84(6):1085-6. DOI: 10.1016/0002-9343(88)90319-1. View

5.
Butler J, Queally J, Devitt B, Murray D, Doran P, OByrne J . Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation. BMC Musculoskelet Disord. 2010; 11:210. PMC: 2946271. DOI: 10.1186/1471-2474-11-210. View